Logo image of SREA

SEMPRA - SRE 5 3/4 07/01/2079 (SREA) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:SREA - US8168516040

22.26 USD
-0.01 (-0.04%)
Last: 12/23/2025, 11:37:35 AM
Fundamental Rating

4

SREA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 26 industry peers in the Multi-Utilities industry. SREA has a medium profitability rating, but doesn't score so well on its financial health evaluation. SREA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SREA had positive earnings in the past year.
In the past year SREA had a positive cash flow from operations.
Each year in the past 5 years SREA has been profitable.
SREA had a positive operating cash flow in each of the past 5 years.
SREA Yearly Net Income VS EBIT VS OCF VS FCFSREA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B

1.2 Ratios

With a Return On Assets value of 1.97%, SREA is not doing good in the industry: 80.77% of the companies in the same industry are doing better.
SREA's Return On Equity of 6.77% is on the low side compared to the rest of the industry. SREA is outperformed by 80.77% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.94%, SREA is doing worse than 92.31% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SREA is in line with the industry average of 3.94%.
Industry RankSector Rank
ROA 1.97%
ROE 6.77%
ROIC 2.94%
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
SREA Yearly ROA, ROE, ROICSREA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 15.38%, SREA belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
In the last couple of years the Profit Margin of SREA has grown nicely.
SREA has a better Operating Margin (22.51%) than 69.23% of its industry peers.
In the last couple of years the Operating Margin of SREA has declined.
Industry RankSector Rank
OM 22.51%
PM (TTM) 15.38%
GM N/A
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
SREA Yearly Profit, Operating, Gross MarginsSREA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SREA is destroying value.
SREA has more shares outstanding than it did 1 year ago.
SREA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SREA has a worse debt to assets ratio.
SREA Yearly Shares OutstandingSREA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SREA Yearly Total Debt VS Total AssetsSREA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

SREA has an Altman-Z score of 0.70. This is a bad value and indicates that SREA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.70, SREA is in line with its industry, outperforming 42.31% of the companies in the same industry.
A Debt/Equity ratio of 1.02 is on the high side and indicates that SREA has dependencies on debt financing.
SREA has a better Debt to Equity ratio (1.02) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF N/A
Altman-Z 0.7
ROIC/WACC0.61
WACC4.81%
SREA Yearly LT Debt VS Equity VS FCFSREA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

SREA has a Current Ratio of 1.59. This is a normal value and indicates that SREA is financially healthy and should not expect problems in meeting its short term obligations.
SREA's Current ratio of 1.59 is amongst the best of the industry. SREA outperforms 100.00% of its industry peers.
SREA has a Quick Ratio of 1.56. This is a normal value and indicates that SREA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of SREA (1.56) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.56
SREA Yearly Current Assets VS Current LiabilitesSREA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.24% over the past year.
Measured over the past years, SREA shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.31% on average per year.
SREA shows a small growth in Revenue. In the last year, the Revenue has grown by 6.14%.
The Revenue has been growing slightly by 4.04% on average over the past years.
EPS 1Y (TTM)16.24%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%24.72%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%13.51%

3.2 Future

SREA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.96% yearly.
Based on estimates for the next years, SREA will show a decrease in Revenue. The Revenue will decrease by -0.86% on average per year.
EPS Next Y-0.11%
EPS Next 2Y5.64%
EPS Next 3Y6.66%
EPS Next 5Y6.96%
Revenue Next Year-11.37%
Revenue Next 2Y-3.57%
Revenue Next 3Y-2.54%
Revenue Next 5Y-0.86%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SREA Yearly Revenue VS EstimatesSREA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
SREA Yearly EPS VS EstimatesSREA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.51, which indicates a rather cheap valuation of SREA.
84.62% of the companies in the same industry are more expensive than SREA, based on the Price/Earnings ratio.
SREA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.61.
Based on the Price/Forward Earnings ratio of 4.32, the valuation of SREA can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SREA indicates a rather cheap valuation: SREA is cheaper than 84.62% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.01, SREA is valued rather cheaply.
Industry RankSector Rank
PE 4.51
Fwd PE 4.32
SREA Price Earnings VS Forward Price EarningsSREA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SREA is valued cheaper than 84.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.01
SREA Per share dataSREA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.64%
EPS Next 3Y6.66%

3

5. Dividend

5.1 Amount

SREA has a Yearly Dividend Yield of 2.96%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.56, SREA's dividend is way lower than its industry peers. On top of this 84.62% of the companies listed in the same industry pay a better dividend than SREA!
Compared to an average S&P500 Dividend Yield of 1.87, SREA pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.96%

5.2 History

The dividend of SREA decreases each year by -9.71%.
SREA has been paying a dividend for over 5 years, so it has already some track record.
SREA has decreased its dividend recently.
Dividend Growth(5Y)-9.71%
Div Incr Years0
Div Non Decr Years1
SREA Yearly Dividends per shareSREA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

76.67% of the earnings are spent on dividend by SREA. This is not a sustainable payout ratio.
DP76.67%
EPS Next 2Y5.64%
EPS Next 3Y6.66%
SREA Yearly Income VS Free CF VS DividendSREA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
SREA Dividend Payout.SREA Dividend Payout, showing the Payout Ratio.SREA Dividend Payout.PayoutRetained Earnings

SEMPRA - SRE 5 3/4 07/01/2079

NYSE:SREA (12/23/2025, 11:37:35 AM)

22.26

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners95.73%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap14.53B
Revenue(TTM)13.71B
Net Income(TTM)2.11B
Analysts78.18
Price Target25.12 (12.85%)
Short Float %0%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield 2.96%
Yearly Dividend2.41
Dividend Growth(5Y)-9.71%
DP76.67%
Div Incr Years0
Div Non Decr Years1
Ex-Date12-15 2025-12-15 (0.3594)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.33%
Min EPS beat(2)4.16%
Max EPS beat(2)20.49%
EPS beat(4)3
Avg EPS beat(4)6.38%
Min EPS beat(4)-7.18%
Max EPS beat(4)20.49%
EPS beat(8)4
Avg EPS beat(8)0.32%
EPS beat(12)8
Avg EPS beat(12)2.78%
EPS beat(16)12
Avg EPS beat(16)4.05%
Revenue beat(2)1
Avg Revenue beat(2)1.51%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)7.1%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-14.67%
Max Revenue beat(4)7.1%
Revenue beat(8)1
Avg Revenue beat(8)-12.45%
Revenue beat(12)2
Avg Revenue beat(12)-5.38%
Revenue beat(16)6
Avg Revenue beat(16)-1.3%
PT rev (1m)6.23%
PT rev (3m)3.75%
EPS NQ rev (1m)-1.84%
EPS NQ rev (3m)-4.43%
EPS NY rev (1m)0.75%
EPS NY rev (3m)1.1%
Revenue NQ rev (1m)-0.84%
Revenue NQ rev (3m)12.15%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-1.89%
Valuation
Industry RankSector Rank
PE 4.51
Fwd PE 4.32
P/S 1.06
P/FCF N/A
P/OCF 3.06
P/B 0.47
P/tB 0.47
EV/EBITDA 8.01
EPS(TTM)4.94
EY22.19%
EPS(NY)5.16
Fwd EY23.16%
FCF(TTM)-9.02
FCFYN/A
OCF(TTM)7.26
OCFY32.63%
SpS21.01
BVpS47.76
TBVpS47.76
PEG (NY)N/A
PEG (5Y)N/A
Graham Number72.86
Profitability
Industry RankSector Rank
ROA 1.97%
ROE 6.77%
ROCE 3.55%
ROIC 2.94%
ROICexc 2.94%
ROICexgc 2.94%
OM 22.51%
PM (TTM) 15.38%
GM N/A
FCFM N/A
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
ROICexc(3y)3.32%
ROICexc(5y)3.56%
ROICexgc(3y)3.41%
ROICexgc(5y)3.66%
ROCE(3y)3.99%
ROCE(5y)4.26%
ROICexgc growth 3Y-8.37%
ROICexgc growth 5Y-5.96%
ROICexc growth 3Y-8.1%
ROICexc growth 5Y-5.8%
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF N/A
Debt/EBITDA 5.6
Cap/Depr 411.78%
Cap/Sales 77.51%
Interest Coverage 2.32
Cash Conversion 83.66%
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.56
Altman-Z 0.7
F-Score5
WACC4.81%
ROIC/WACC0.61
Cap/Depr(3y)359.34%
Cap/Depr(5y)353.45%
Cap/Sales(3y)54.96%
Cap/Sales(5y)53.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.24%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%24.72%
EPS Next Y-0.11%
EPS Next 2Y5.64%
EPS Next 3Y6.66%
EPS Next 5Y6.96%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%13.51%
Revenue Next Year-11.37%
Revenue Next 2Y-3.57%
Revenue Next 3Y-2.54%
Revenue Next 5Y-0.86%
EBIT growth 1Y18.88%
EBIT growth 3Y1.29%
EBIT growth 5Y1.48%
EBIT Next Year57.29%
EBIT Next 3Y19.85%
EBIT Next 5Y14.33%
FCF growth 1Y-58.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.56%
OCF growth 3Y8.5%
OCF growth 5Y9.71%

SEMPRA - SRE 5 3/4 07/01/2079 / SREA FAQ

Can you provide the ChartMill fundamental rating for SEMPRA - SRE 5 3/4 07/01/2079?

ChartMill assigns a fundamental rating of 4 / 10 to SREA.


What is the valuation status for SREA stock?

ChartMill assigns a valuation rating of 6 / 10 to SEMPRA - SRE 5 3/4 07/01/2079 (SREA). This can be considered as Fairly Valued.


How profitable is SEMPRA - SRE 5 3/4 07/01/2079 (SREA) stock?

SEMPRA - SRE 5 3/4 07/01/2079 (SREA) has a profitability rating of 4 / 10.


Can you provide the financial health for SREA stock?

The financial health rating of SEMPRA - SRE 5 3/4 07/01/2079 (SREA) is 3 / 10.


What is the earnings growth outlook for SEMPRA - SRE 5 3/4 07/01/2079?

The Earnings per Share (EPS) of SEMPRA - SRE 5 3/4 07/01/2079 (SREA) is expected to decline by -0.11% in the next year.